Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0758
D

Inadequate Management of Psychotropic Medications

Peckville, Pennsylvania Survey Completed on 04-23-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to manage and monitor medication regimens effectively for Resident 4, who was admitted with diagnoses including dementia with mood disturbances, anxiety, and a history of falling. The resident was severely cognitively impaired, as indicated by a BIMS score of 4. The care plan identified potential for distressed mood and behavioral symptoms, with interventions including medication per physician order and gradual dose reduction. However, a physician's order increased the dosage of Geodon, an antipsychotic medication, without documented behavioral evaluations, psychiatric reassessments, or non-pharmacological interventions. Additionally, there was no resident-specific rationale for the concurrent use of Geodon and Ativan, an antianxiety medication, nor was there documentation of gradual dose reduction or interdisciplinary team discussion. The deficiency was further evidenced by the resident experiencing three falls with injury, requiring emergency room visits, and the lack of documentation supporting the medication changes. An observation noted the resident sleeping in the activity room, while other residents participated in activities. The Director of Nursing confirmed the absence of resident-specific documentation to justify the increase in antipsychotic medication or the continued use of both psychoactive medications for Resident 4.

An unhandled error has occurred. Reload 🗙